Sunday, November 30, 2025 2:53:58 AM
You were asking, finally got time.
Affluence’s share structure data here point to very heavy dilution in a short time, driven almost entirely by new common shares rather than changes to authorized or restricted stock.
What the numbers show
Authorized shares stay flat at 25.1 billion the whole time, so the board has not yet reduced the capital ceiling; all the action is in outstanding and DTC-held shares.Between 22 Aug 2025 and 21 Nov 2025, outstanding shares rise from about 5.69B to 11.40B—an increase of roughly 5.7B shares (~100%) in three months, with unrestricted and DTC-held counts moving in lockstep, meaning almost all of the new paper is free-trading common stock.
Likely drivers and implications: The step-wise jumps (e.g., 5.69B ? 6.12B ? 7.22B ? 7.67B ? 8.69B ? 9.38B ? 10.75B ? 11.40B) are consistent with batches of debt or payables being converted into equity, which aligns with management’s stated plan to use common shares to retire “toxic” legacy debt as part of its “financial reset.”
From a shareholder perspective, this confirms extreme short-term dilution risk: existing holders have seen their percentage ownership massively compressed, and there is still large unused authorization (over 13B shares) that could be tapped unless the company moves to cap or reverse-split the float.
What can be inferred about the accountant’s point. Tracking these dates the way that poster did demonstrates that dilution is ongoing, mechanical, and largely predictable from the cleanup strategy, rather than random insider dumping; that nuance matters when assessing intent and governance.
At the same time, the scale and pace of issuance underscore that any future value creation (e.g., acquisitions, uplisting) must overcome a very bloated share count, so investors should model returns per share after dilution, not just look at operating improvements or revenue headlines.
Affluence’s share structure data here point to very heavy dilution in a short time, driven almost entirely by new common shares rather than changes to authorized or restricted stock.
What the numbers show
Authorized shares stay flat at 25.1 billion the whole time, so the board has not yet reduced the capital ceiling; all the action is in outstanding and DTC-held shares.Between 22 Aug 2025 and 21 Nov 2025, outstanding shares rise from about 5.69B to 11.40B—an increase of roughly 5.7B shares (~100%) in three months, with unrestricted and DTC-held counts moving in lockstep, meaning almost all of the new paper is free-trading common stock.
Likely drivers and implications: The step-wise jumps (e.g., 5.69B ? 6.12B ? 7.22B ? 7.67B ? 8.69B ? 9.38B ? 10.75B ? 11.40B) are consistent with batches of debt or payables being converted into equity, which aligns with management’s stated plan to use common shares to retire “toxic” legacy debt as part of its “financial reset.”
From a shareholder perspective, this confirms extreme short-term dilution risk: existing holders have seen their percentage ownership massively compressed, and there is still large unused authorization (over 13B shares) that could be tapped unless the company moves to cap or reverse-split the float.
What can be inferred about the accountant’s point. Tracking these dates the way that poster did demonstrates that dilution is ongoing, mechanical, and largely predictable from the cleanup strategy, rather than random insider dumping; that nuance matters when assessing intent and governance.
At the same time, the scale and pace of issuance underscore that any future value creation (e.g., acquisitions, uplisting) must overcome a very bloated share count, so investors should model returns per share after dilution, not just look at operating improvements or revenue headlines.

